Official Title
Prevalence and Clinical Evolution of Olfactory and Taste Disorders in Patients Infected by SARS-CoV-2
Brief Summary

A novel coronavirus SARS-CoV-2 HAS arose in 2019 in Wuhan, China. Beside the classical semiology of this infection, numerous patients described olfactory and teste disorders. These symptoms are not described in this coronavirus, neurotropism of coronaviridae has been documented before. The aim of the study is to evaluate prevalence of anosmia and dysgeusia (olfactory and taste disorders) in coronavirus diagnosed patients and compare with different clinical conditions. The second endpoint is to evaluate the duration of these symptoms in order to better understand the semiology of this infection.

Status
Unknown status
Conditions
COVID-19 by SARS-CoV-2 Infection
Eligibility Criteria

Inclusion Criteria:

- COVID-19 diagnosed

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
France
Locations

CHU de Nice
Nice, France

Sponsors / Collaborators
Centre Hospitalier Universitaire de Nice
NCT Number
NCT04361565
MeSH Terms
COVID-19
Taste Disorders